DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure.

Cardiovasc Diabetol · 2014 · PMC4255443 · PMID 25471116

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Linagliptin treatment tended to reduce cardiac MCP-1 mRNA levels in high-salt fed DS rats, although the difference did not reach statistical significance (Figure 4 (D)).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.